Dalia Bashari

466 total citations
19 papers, 343 citations indexed

About

Dalia Bashari is a scholar working on Hematology, Hepatology and Epidemiology. According to data from OpenAlex, Dalia Bashari has authored 19 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 7 papers in Hepatology and 5 papers in Epidemiology. Recurrent topics in Dalia Bashari's work include Hemophilia Treatment and Research (15 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (5 papers). Dalia Bashari is often cited by papers focused on Hemophilia Treatment and Research (15 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (5 papers). Dalia Bashari collaborates with scholars based in Israel, Russia and France. Dalia Bashari's co-authors include Gili Kenet, Mudi Misgav, Einat Avishai, Tami Livnat, Ivan Budnik, U. Martinowitz, Tami Brutman‐Barazani, Jonathan Schapiro, Aharon Lubetsky and Jacob Luboshitz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Dalia Bashari

19 papers receiving 336 citations

Peers

Dalia Bashari

HEMAT

GENET

HEPAT

EPIDE

SURGE

Geet Aggarwal India

Ana Boban Croatia

Benjamin Rioux‐Massé Canada

P. Fabrigli France

Carolina Bonet Bub Brazil

Diego Tempesta Italy

Flavia Sequeira United States

Marı́a L. Marty Spain

Ciro Fulgaro Italy

Margaret Hoyle United States

Geet Aggarwal India

Dalia Bashari

74 ×0.3

HEMAT

38 ×0.5

GENET

31 ×0.4

HEPAT

41 ×0.6

EPIDE

29 ×1.3

SURGE

Citations per year, relative to Dalia Bashari Dalia Bashari (= 1×) peers Geet Aggarwal

Countries citing papers authored by Dalia Bashari

Since Specialization

Citations

This map shows the geographic impact of Dalia Bashari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalia Bashari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalia Bashari more than expected).

Fields of papers citing papers by Dalia Bashari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalia Bashari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalia Bashari. The network helps show where Dalia Bashari may publish in the future.

Co-authorship network of co-authors of Dalia Bashari

This figure shows the co-authorship network connecting the top 25 collaborators of Dalia Bashari. A scholar is included among the top collaborators of Dalia Bashari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalia Bashari. Dalia Bashari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Budnik, Ivan, Einat Avishai, Tami Brutman‐Barazani, et al.. (2021). Emicizumab prophylaxis: Prospective longitudinal real‐world follow‐up and monitoring. Haemophilia. 27(3). 383–391. 48 indexed citations

Misgav, Mudi, Tami Brutman‐Barazani, Ivan Budnik, et al.. (2021). Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real‐world data. Haemophilia. 27(2). 253–260. 31 indexed citations

Lalezari, Shadan, Assaf Arie Barg, Rima Dardik, et al.. (2021). Women with Hemophilia: Case Series of Reproductive Choices and Review of Literature. SHILAP Revista de lepidopterología. 5(2). e183–e187. 5 indexed citations

Barg, Assaf Arie, Einat Avishai, Ivan Budnik, et al.. (2020). The potential role of emicizumab prophylaxis in severe von Willebrand disease. Blood Cells Molecules and Diseases. 87. 102530–102530. 21 indexed citations

Barg, Assaf Arie, Tami Livnat, Ivan Budnik, et al.. (2020). Emicizumab treatment and monitoring in a paediatric cohort: real‐world data. British Journal of Haematology. 191(2). 282–290. 60 indexed citations

Barg, Assaf Arie, Gili Kenet, Tami Livnat, et al.. (2020). The Potential Role of Emicizuamb Prophylaxis in Severe Von Willebrand Disease. Blood. 136(Supplement 1). 20–20. 1 indexed citations

Salomon, Ophira, Ivan Budnik, Einat Avishai, et al.. (2019). Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery. Thrombosis and Haemostasis. 119(12). 1927–1932. 13 indexed citations

Lubetsky, Aaron, et al.. (2014). Oral surgery‐associated postoperative bleeding in haemophilia patients – a tertiary centre's two decade experience. Haemophilia. 21(2). 234–240. 17 indexed citations

Maor‬‏, ‪Yasmin, Jonathan Schapiro, Dalia Bashari, & U. Martinowitz. (2014). Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment. Annals of Hepatology. 13(6). 753–761. 12 indexed citations

10.

Maor‬‏, ‪Yasmin, Gilles A. Morali, Dalia Bashari, et al.. (2012). Genetic polymorphism of IL28B in hepatitis C‐infected haemophilia patients in Israel. Haemophilia. 19(1). 150–156. 6 indexed citations

11.

Strauss, Tzipora, Aharon Lubetsky, B. Ravid, et al.. (2011). Recombinant factor concentrates may increase inhibitor development: a single centre cohort study. Haemophilia. 17(4). 625–629. 23 indexed citations

12.

Maor‬‏, ‪Yasmin, Philippe Halfon, Dalia Bashari, et al.. (2009). Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C. Haemophilia. 16(1). 148–154. 10 indexed citations

13.

Martinowitz, U., Jacob Luboshitz, Dalia Bashari, et al.. (2009). Stability, efficacy, and safety of continuously infused sucrose‐formulated recombinant factor VIII (rFVIII‐FS) during surgery in patients with severe haemophilia. Haemophilia. 15(3). 676–685. 22 indexed citations

14.

Maor‬‏, ‪Yasmin, Jonathan Schapiro, Dalia Bashari, et al.. (2008). Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience. Haemophilia. 14(2). 336–342. 7 indexed citations

15.

Maor‬‏, ‪Yasmin, Paul Calès, Dalia Bashari, et al.. (2007). Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C‐infected haemophilia patients. Haemophilia. 13(6). 722–729. 14 indexed citations

16.

Maor‬‏, ‪Yasmin, Dalia Bashari, Gili Kenet, et al.. (2006). Hepatitis C at the Israeli National Hemophilia Center. Haemophilia. 12(1). 68–74. 14 indexed citations

17.

Maor‬‏, ‪Yasmin, Dalia Bashari, Gili Kenet, et al.. (2006). Non‐invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?. Haemophilia. 12(4). 372–379. 25 indexed citations

18.

Varon, D., Sam Schulman, Dalia Bashari, & U. Martinowitz. (1996). Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage. Haemophilia. 2(4). 207–210. 9 indexed citations

19.

Varon, D., Sam Schulman, Rima Dardik, et al.. (1994). High Versus Ultra-high Purity Factor VIII Concentrate Therapy: Prospective Evaluation of Immunological and Clinical Parameters in HIV Seronegative and Seropositive Hemophiliacs. Thrombosis and Haemostasis. 72(3). 359–362. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact